Mycophenolate mofetil for myasthenia gravis: a clear and present controversy
Chad Heatwole, Emma CiafaloniDepartment of Neurology, The University of Rochester, Rochester, New York, USAAbstract: Mycophenolate mofetil (MMF) has been used to treat myasthenia gravis (MG) for over 10 years. MMF’s use in the MG population stems from its theoretical mechanism of actio...
Guardado en:
Autores principales: | Chad Heatwole, Emma Ciafaloni |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c86069ab9fb4db2873d6c827b7de2e2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current and emerging therapies for the treatment of myasthenia gravis
por: Renato Mantegazza, et al.
Publicado: (2011) -
Clinical Evaluation of the Efficacy and Safety of Co-Administration of Wuzhi Capsule and Tacrolimus in Adult Chinese Patients with Myasthenia Gravis
por: Peng Y, et al.
Publicado: (2021) -
Prognostic Analysis of Thymoma-Associated Myasthenia Gravis (MG) in Chinese Patients and Its Implication of MG Management: Experiences from a Tertiary Hospital
por: Chen D, et al.
Publicado: (2020) -
Association Between Myasthenia Gravis and Memory: A Systematic Review and Meta-Analysis
por: Xiaoling Zhou, et al.
Publicado: (2021) -
Comorbid Autoimmune Diseases in Patients With Myasthenia Gravis: A Retrospective Cross-Sectional Study of a Chinese Cohort
por: Jianquan Shi, et al.
Publicado: (2021)